Last updated: July 05, 2026

Application No. 18/716,748

Herbicidal Compositions

Non-Final OA

Filed

Jun 05, 2024

Priority

Dec 06, 2021 — GB 2117597.1 +1 more

Examiner

ALLEY, GENEVIEVE S

Art Unit

1617

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Syngenta Crop Protection LLC

OA Round

1 (Non-Final)

Interview Optional

— +48.9% interview lift. Interview already conducted in this application's prosecution history. This examiner has a 60% grant rate with +48.9% interview lift. Since an interview has already been tried, recommend written response with narrowed claims based on precedent claim evolution patterns.

Based on 724 resolved cases, 2023–2026

Examiner Intelligence

ALLEY, GENEVIEVE S View full profile →

Grants 60% of resolved cases

Career Allowance Rate

436 granted / 724 resolved

At TC average

Strong +49% interview lift

Without

With

+48.9%

Interview Lift

resolved cases with interview

Typical timeline

2y 11m

Avg Prosecution

41 currently pending

Career history

770

Total Applications

across all art units

Statute-Specific Performance

§101

0.4%

-39.6% vs TC avg

§103

66.7%

+26.7% vs TC avg

§102

6.8%

-33.2% vs TC avg

§112

2.6%

-37.4% vs TC avg

Black line = Tech Center average estimate • Based on career data from 724 resolved cases

Prosecution Timeline

Jun 05, 2024

Application Filed

Feb 25, 2026

Examiner Interview (Telephonic)

Mar 16, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/367,542

Patent 12668649

MONOGLYCEROL ACRYLATE BASED POLYMER AND USES THEREOF

2y 6m to grant Granted Jun 30, 2026

18/506,386

Patent 12667547

USE OF CYSTEAMINE AND DERIVATIVES THEREOF TO SUPPRESS TUMOR METASTASES

2y 7m to grant Granted Jun 30, 2026

17/625,451

Patent 12648567

MICROBIAL COMPOSITIONS

4y 5m to grant Granted Jun 09, 2026

17/774,922

Patent 12648937

COMPOSITION CONTAINING LEVAMLODIPINE BESYLATE HYDRATE AND ITS PREPARATION METHOD

4y 1m to grant Granted Jun 09, 2026

18/170,185

Patent 12636289

LAMOTRIGINE ORAL LIQUID SUSPENSION AND USE THEREOF

3y 3m to grant Granted May 26, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

60%

Grant Probability

99%

With Interview (+48.9%)

2y 11m (~10m remaining)

Median Time to Grant

Low

PTA Risk

Based on 724 resolved cases by this examiner. Grant probability derived from career allowance rate.